PTC596 free base · Synonyms: Unesbulin
PTC596 is an orally active and selective B-cell-specific Moloney murine leukemia virus integration site 1 inhibitor.
For research use only. Not for human or veterinary use.
PTC596 structure
CAS No.: 1610964-64-1
Pack sizes & pricing
| Size | Price | SKU | Stock | |
|---|---|---|---|---|
| 100 mg | USD 480.00 | BP-01904-100mg | In stock | Get quote |
| 250 mg | USD 920.00 | BP-01904-250mg | In stock | Get quote |
| 500 mg | USD 1,420.00 | BP-01904-500mg | In stock | Get quote |
| 1 g | USD 2,120.00 | BP-01904-1g | In stock | Get quote |
| 5 g | Inquire | BP-01904-5g | Inquire | Inquire |
Need another size or custom synthesis? Request a quote.
Description
PTC596 is an orally active and selective B-cell-specific Moloney murine leukemia virus integration site 1 (BMI-1) inhibitor. PTC596 targets BMI1 expressed by both tumor cells and cancer stem cells (CSCs), and induces hyper-phosphorylation of BMI1, leading to its degradation.
Biological activity
In Vitro Unesbulin (PTC596; 20-200 nM; for 48 hours) induces apoptosis in AML cells in a p53-independent manner. BMI-1 overexpression desensitizes AML cells to PTC596-induced apoptosis. Unesbulin (200 nM; for 10 hours) leads to an accumulation of cells in G2/M phase. Unesbulin (0.012-1 μM; for 20 hours) significantly reduces protein levels of BMI-1. Unesbulin inhibits APC/CCDC20 activity resulting in the persistent activation of CDK1 and CDK2 which mediate the hyperphosphorylation of BMI1. In Vivo Unesbulin (PTC596; 5 mg/kg; oral gavage; every 3 days for 13 days) significantly prolongs mouse survival. Unesbulin (20 mg/kg; oral gavage; once a week for 15 days) causes tumor volume significantly smaller than that of control SCID mice with K562 cells. Unesbulin (10 or 12.5 mg/kg; oral gavage; twice a week until death) causes the survival significantly longer than the vehicle-treated group in NOD-SCID mice with HL-60 cells.
Identifiers
- SMILES
-
NC1=C(F)C(NC2=CC=C(C(F)(F)F)C=C2)=NC(N3C4=CC(F)=CC=C4N=C3C)=N1 - InChIKey
-
TWLWOOPCEXYVBE-UHFFFAOYSA-N
Specifications
- MW (average)
- 420.3387
- Formula
- C19H13F5N6
- CAS No.
- 1610964-64-1
- Physical state
- Solid
- Color
- White to off-white
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20℃ 3 years; 4℃ 2 years; In solvent -20℃ 1 month;
Solubility
Soluble in DMSO
Documents
References
Same target
Search BMI1- BP-00104 BMS-986397 free base · >98%
- BP-00752 CR-1-31-B free base · >98%
- BP-01119 BRD-810 free base · >98%
- BP-01218 ME-344 free base · >98%
- BP-01346 GSK-3484862 free base · >98%
- BP-01745 CPUY192018 free base · >98%
- BP-01861A Nirogacestat dihydrobromide salt · >98%
- BP-01900 IACS-10759 free base · >98%
Same research area
Search Cancer- BP-00084 ORIC-944 free base · >98%
- BP-00343 Opadotin free base · >98%
- BP-00756 PF-07853578 free base · >98%
- BP-00771A dTAGV-1 hydrochloride salt · >98%
- BP-00882 OPB-171775 free base · HPLC >98%, ee>98%
- BP-00998 BGB-116673 analog free base · >98%
- BP-01217 RAD51-IN-2 free base · >98%
- BP-01260 Rezivertinib free base · >98%